First At-Home Cervical Cancer Screening Tool Gets FDA Clearance

The US FDA has approved the Teal Wand, the first at-home cervical cancer screening device. Capable of detecting preclinical cancer with 96% accuracy, it will launch in California in June and expand nationwide soon after.

Teal Health’s Teal Wand self-collection device for at-home cervical cancer screening
Teal Health’s Teal Wand self-collection device for at-home cervical cancer screening (Nicole Morrison/Teal Health)

More from Women's Health

More from Diagnostics